| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/08/2010 | CN101011495B Kidney tonifying pill preparation made of fish air bladder and its preparation |
| 09/07/2010 | US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 09/07/2010 | US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents |
| 09/07/2010 | US7790764 Biologically active macrolides, compositions, and uses thereof |
| 09/07/2010 | US7790749 Antiulcer agents; gastrointestinal disorders; anticancer agents; anemia |
| 09/07/2010 | US7790736 Dipeptidyl peptidase inhibitors |
| 09/07/2010 | US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes |
| 09/07/2010 | US7790713 Inhibitors of interleukin-1β converting enzyme |
| 09/07/2010 | US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample |
| 09/07/2010 | US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 09/07/2010 | US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases |
| 09/07/2010 | CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/02/2010 | WO2010098286A1 Pharmaceutical preparation containing mineralcorticoid receptor antagonist |
| 09/02/2010 | WO2010098265A1 Polymeric micelle containing proteasome inhibitor |
| 09/02/2010 | US20100222404 Indazole derivative dihydrochloride |
| 09/02/2010 | US20100222393 Muscarinic receptor antagonists |
| 09/02/2010 | US20100222375 Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration |
| 09/02/2010 | US20100222334 Pharmaceutical Formulation of Valsartan |
| 09/02/2010 | US20100222286 Receptor modulators exhibiting neuroprotective and memory enhancing activities |
| 09/02/2010 | US20100222283 Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal desease |
| 09/02/2010 | US20100222282 Method of diagnosis and method of treatment |
| 09/02/2010 | US20100222274 Glycosylation-deficient hepatocyte growth factor |
| 09/02/2010 | US20100221761 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/02/2010 | US20100221356 Pharmaceutical composition for once a day administration of trospium chloride |
| 09/02/2010 | US20100221355 Pharmaceutical composition for once-a-day oral administration of trospium chloride |
| 09/02/2010 | US20100221354 Pharmaceutical composition for once-a-day oral administration of trospium chloride |
| 09/02/2010 | US20100221353 Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride |
| 09/02/2010 | US20100221352 Pharmaceutical composition for the once-a-day oral administration of trospium chloride |
| 09/02/2010 | US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 09/02/2010 | US20100221317 Dynamin mediated diseases and associated methods and products |
| 09/02/2010 | US20100221221 N-phenyl-2-pyrimidineamine derivatives |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2223690A1 Pharmaceutical composition for ameliorating lower urinary tract symptom |
| 09/01/2010 | EP2222666A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
| 09/01/2010 | EP2222301A1 Method and composition for treating an alpha adrenoceptor-mediated condition |
| 09/01/2010 | EP2222295A2 Pharmaceutical composition for treatment and prevention of kidney diseases |
| 09/01/2010 | EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/01/2010 | EP1408117B1 Glycoprotein and process for producing the same |
| 09/01/2010 | EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 09/01/2010 | CN201564811U Traditional medicinal tablet for treating nephritis |
| 09/01/2010 | CN1969855B Pharmaceutical composition having target organ protection function and usage thereof |
| 09/01/2010 | CN1857337B Use of patrinia herb and its extract in preparing medicine for treating prostatic hyperplasia |
| 09/01/2010 | CN101821253A Piperidine derivative |
| 09/01/2010 | CN101821243A Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 09/01/2010 | CN101820914A Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 09/01/2010 | CN101820882A Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 09/01/2010 | CN101817940A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same |
| 09/01/2010 | CN101817861A Method for preparing high-purity astragaloside for treating diabetes nephropathy and peripheral neuritis of diabetes complications |
| 09/01/2010 | CN101817808A Flavones derivative as well as preparation method and application thereof as alpha1 receptor antagonist |
| 09/01/2010 | CN101816818A Multifunctional saline-alkaline heat transfer treatment chair and preparation method thereof |
| 09/01/2010 | CN101816754A Orally-administered Chinese medicinal composition for treating acute gestational urinary infection |
| 09/01/2010 | CN101816749A Medicament for curing dysuria, preparation method and quality control method thereof |
| 09/01/2010 | CN101816715A Method for measuring content of Danshensu in shenshuaining capsules by utilizing HPLC method |
| 09/01/2010 | CN101816701A Process for preparing kudzu root extract instant grains |
| 09/01/2010 | CN101816685A Hydroxyl-containing acid extract for preventing and treating prostate cancer, and extraction method and application thereof |
| 09/01/2010 | CN101816684A Method for microwave extraction and macroporous resin purification of flavone from herbaceous plants |
| 09/01/2010 | CN101816655A Medicinal preparation containing repaglinide and ligustrazine and application thereof in diabetic complications |
| 09/01/2010 | CN101816638A Methods and formulations for modulating the human sexual response |
| 09/01/2010 | CN101190327B 'Kanlijiaobuye' a kind of traditional Chinese medicinal oral liquid |
| 09/01/2010 | CN101081865B Abstraction of pilose antler releasing somatomedin (DEER GHRF) and preparation method thereof |
| 08/31/2010 | US7786110 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 08/31/2010 | US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 08/31/2010 | US7785870 Cell-specific expression/replication vector |
| 08/31/2010 | US7785811 Using lutetium label probes to detect tumor secreted antigens and diagnose/prognose cell proliferative disorders |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/26/2010 | WO2010095808A2 Production method for astragalus membranaceus extract employing enzymolysis, and a composition for preventing or alleviating diabetes or obesity containing an active ingredient comprising an astragalus membranaceus extract produced by means of the production method |
| 08/26/2010 | WO2010095706A1 Novel anti-inflammatory compounds |
| 08/26/2010 | WO2010095663A1 Fused heterocyclic ring compound |
| 08/26/2010 | WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same |
| 08/26/2010 | WO2010094644A1 Substituted pyridine derivatives and their medical use |
| 08/26/2010 | WO2010077883A3 Antagonists of lysophosphatidic acid receptors |
| 08/26/2010 | US20100216871 Use of compounds having ccr antagonism |
| 08/26/2010 | US20100216819 Thiazolopyrimidines for Use in Therapy |
| 08/26/2010 | US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products |
| 08/26/2010 | US20100216803 Ornithine derivative |
| 08/26/2010 | US20100216801 Thiazolones for use as pi3 kinase inhibitors |
| 08/26/2010 | US20100216794 Pyridine derivatives useful as glucokinase activators |
| 08/26/2010 | US20100216787 Thiazole derivative |
| 08/26/2010 | US20100216786 New compounds |
| 08/26/2010 | US20100216785 Pharmaceutical compositions |
| 08/26/2010 | US20100216758 Pyridone Compounds |
| 08/26/2010 | US20100216745 Novel cephem compounds useful for the treatment of bacterial infections |
| 08/26/2010 | US20100216726 Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof |
| 08/26/2010 | US20100215770 Mixed metal compounds for treatment of hyperphosphataemia |
| 08/26/2010 | US20100215764 Pharmaceutical Composition For Treating Nephropathy and Healthy Food Comprising Herb Extracts |
| 08/26/2010 | US20100215750 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 08/26/2010 | US20100215741 Pharmaceutical compounds |
| 08/26/2010 | US20100215702 Microparticles comprising pcl and uses thereof |
| 08/26/2010 | US20100215661 Nicotinamide derivates useful as p38 inhibitors |
| 08/26/2010 | US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 08/26/2010 | US20100215652 Nicotinamide derivates useful as p38 inhibitors |
| 08/25/2010 | EP2221308A1 Benzazepinone compound |
| 08/25/2010 | EP2221301A1 Heteroaryloxy quinazoline derivative |
| 08/25/2010 | EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 08/25/2010 | EP2220029A1 Novel compounds |
| 08/25/2010 | EP2219661A1 Compositions for tissue repair/regeneration |
| 08/25/2010 | EP2219650A1 Compositions and methods for treating fibroproliferative disorders |
| 08/25/2010 | EP2219627A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 08/25/2010 | EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors |
| 08/25/2010 | CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |